Sabby Management’s Gilead Sciences GILD Stock Holding History

Sabby Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-45,140	Closed	-$4.7M	–	341
2015 Q3	$4.43M	Buy	+45,140	New	+$5.01M	0.18%	92
2015 Q1	–	Sell	-113,260	Closed	-$11.5M	–	309
2014 Q4	$10.7K	Buy	+113,260	New	+$11.7M	0.34%	38
2014 Q2	–	Sell	-155,073	Closed	-$12.1M	–	270
2014 Q1	$11M	Buy	155,073 +77,073	+99%	+$6.04M	0.62%	39
2013 Q4	$5.86M	Sell	78,000 -76,871	-50%	-$5.35M	0.37%	45
2013 Q3	$9.73M	Sell	154,871 -19,237	-11%	-$1.15M	0.63%	39
2013 Q2	$8.92M	Buy	+174,108	New	+$9.08M	0.6%	40

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sabby Management's GILD Position: Q4 2015 in Review

Sabby Management sold out of Gilead Sciences (GILD) in Q4 2015, closing a stake of 45,140 shares — an estimated $4.7M sold.

Sabby Management first reported a position in GILD in Q2 2013 and held it in 6 quarters. The position peaked at $11M in Q1 2014. 1,628 funds tracked by Wall St. Rank hold GILD as of Q4 2015.

Sabby Management reported no remaining Gilead Sciences position as of Q4 2015 after selling out during the quarter.
Sabby Management sold 45,140 Gilead Sciences shares in Q4 2015, an estimated $4.7M.
Sabby Management first reported a position in Gilead Sciences in Q2 2013 and held it in 6 quarters.
Sabby Management's Gilead Sciences position peaked at $11M in Q1 2014.
1,628 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2015.

Based on Sabby Management's 13F filing for Q4 2015, filed 16 Feb 2016.